 BOULDER, Colo.--BUSINESS WIRE--- BDSX patientsfirst--Biodesix, Inc. Nasdaq: BDSX, a leading data-driven diagnostic solutions company, today announced in partnership with Seer, Inc. NASDAQ: SEER, a life sciences company commercializing a disruptive new platform for proteomics, a webinar to present the newest trends in proteomics for biomarker discovery and translational research. The webinar entitled A New Era in Precision Medicine - Uncovering the Depth Breadth of the Plasma Proteome with Novel Proteomi 